Since TYMS downregulation reduced hTS5278 cell proliferation in vitro and delayed tumor growth in NSG mice in vivo (Fig. 4), we asked whether TS shRNA treatment prolongs survival of hTS/Ink4a/Arf−/− mice. Here, CDKN2A is linked to neoplasm.